Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1991 Sep;32(3):387–391. doi: 10.1111/j.1365-2125.1991.tb03917.x

The effects of selective beta-adrenoceptor antagonists and partial agonist activity on renal function during exercise in normal subjects and those with moderate renal impairment.

D Taverner 1, I G Mackay 1, K Craig 1, M L Watson 1
PMCID: PMC1368536  PMID: 1685667

Abstract

1. The effects of sustained moderate exercise in the sitting position on renal haemodynamics and glomerular filtration were measured in six normotensive patients with moderately impaired renal function and seven age-matched normal volunteers. 2. The changes in the effects of exercise on renal function induced by chronic cardioselective beta-adrenoceptor blockade by drugs with (epanolol) and without intrinsic sympathomimetic activity (atenolol) were examined. 3. Both beta-adrenoceptor blockers attenuated the heart rate increase with exercise, but only atenolol lowered blood pressure significantly. In resting volunteers on atenolol, associated with the fall in blood pressure there was a significant reduction in glomerular filtration rate. 4. Glomerular filtration fell significantly in all groups with exercise, and renal blood flow also fell in parallel. These changes were not influenced by drug treatment. 5. The exercise-induced rise in PRA was suppressed by atenolol but not by epanolol. 6. The renal function and haemodynamic responses to moderate exercise does not appear to be mediated by the systemic renin-angiotensin system or by beta 1-adrenoceptors.

Full text

PDF
387

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bauer J. H. Adrenergic blocking agents and the kidney. J Clin Hypertens. 1985 Sep;1(3):199–221. [PubMed] [Google Scholar]
  2. Beaufils M. Alterations in renal hemodynamics during chronic and acute beta-blockade in humans. Am J Hypertens. 1989 Nov;2(11 Pt 2):233S–236S. doi: 10.1093/ajh/2.11.233s. [DOI] [PubMed] [Google Scholar]
  3. Epstein M., Oster J. R. Beta blockers and renal function: a reappraisal. J Clin Hypertens. 1985 Mar;1(1):85–99. [PubMed] [Google Scholar]
  4. Hespel P., Lijnen P., Vanhees L., Fagard R., Amery A. Beta-adrenoceptors and the regulation of blood pressure and plasma renin during exercise. J Appl Physiol (1985) 1986 Jan;60(1):108–113. doi: 10.1152/jappl.1986.60.1.108. [DOI] [PubMed] [Google Scholar]
  5. Larsen J. S., Pedersen E. B. Comparison of the effects of propranolol and labetalol on renal haemodynamics at rest and during exercise in essential hypertension. Eur J Clin Pharmacol. 1980 Aug;18(2):135–139. doi: 10.1007/BF00561580. [DOI] [PubMed] [Google Scholar]
  6. Leonetti G., Sampieri L., Cuspidi C., Terzoli L., Rupoli L., Fruscio M., Gradnik R., Zanchetti A. Does beta 1-selective agonistic activity interfere with the antihypertensive efficacy of beta 1-selective blocking agents? J Hypertens Suppl. 1985 Dec;3(3):S243–S245. [PubMed] [Google Scholar]
  7. Mackay I. G., Macnicol A. M., Smith H. J., Cumming A. D., Watson M. L. Intrinsic sympathomimetic activity of cardioselective beta-adrenoceptor blockers and effects on renal function. Br J Clin Pharmacol. 1985 Sep;20(3):197–203. doi: 10.1111/j.1365-2125.1985.tb05061.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Man in 't Veld A. J., Schalekamp M. A. Effects of 10 different beta-adrenoceptor antagonists on hemodynamics, plasma renin activity, and plasma norepinephrine in hypertension: the key role of vascular resistance changes in relation to partial agonist activity. J Cardiovasc Pharmacol. 1983;5 (Suppl 1):S30–S45. doi: 10.1097/00005344-198300051-00006. [DOI] [PubMed] [Google Scholar]
  9. Pringle T. H., O'Connor P. C., McNeill A. J., Finch M. B., Riddell J. G., Shanks R. G. Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man. Br J Clin Pharmacol. 1986 Mar;21(3):249–258. doi: 10.1111/j.1365-2125.1986.tb05187.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Roulston J. E., Wathen C. G., Sanger B., Muir A. L. Sample collection and processing for the assay of plasma renin activity. A comparison of anticoagulants and inhibitors. Ann Clin Biochem. 1983 Jul;20(Pt 4):217–219. doi: 10.1177/000456328302000404. [DOI] [PubMed] [Google Scholar]
  11. Smith H. J., Halliday S. E., Earl D. C., Stribling D. Effects of selective (beta-1 and beta-2) and nonselective beta adrenoceptor antagonists on the cardiovascular and metabolic responses to isoproterenol: comparison with ICI 141,292. J Pharmacol Exp Ther. 1983 Jul;226(1):211–216. [PubMed] [Google Scholar]
  12. Taverner D., Craig K., Mackay I., Watson M. L. Effects of exercise on renal function in patients with moderate impairment of renal function compared to normal men. Nephron. 1991;57(3):288–292. doi: 10.1159/000186277. [DOI] [PubMed] [Google Scholar]
  13. Waller D. G. Beta-adrenoceptor partial agonists: a renaissance in cardiovascular therapy? Br J Clin Pharmacol. 1990 Aug;30(2):157–171. doi: 10.1111/j.1365-2125.1990.tb03760.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Wilkinson R. Beta-blockers and renal function. Drugs. 1982 Mar;23(3):195–206. doi: 10.2165/00003495-198223030-00002. [DOI] [PubMed] [Google Scholar]
  15. Wilkinson R., Stevens I. M., Pickering M., Robson V., Hawkins T., Kerr D. N., Harry J. D. A study of the effects of atenolol and propranolol on renal function in patients with essential hypertension. Br J Clin Pharmacol. 1980 Jul;10(1):51–59. doi: 10.1111/j.1365-2125.1980.tb00501.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES